Filters

Phase
    Intervention Type
      Status
        Location:
        LocationClose
        Distance
          Term Search
          You can select from the dropdown list OR enter your own terms to refine the search.

          Last Updated: 10/31/2025

          Need to find the closest trial?
          Sort By Distance
          Save trials for later
          Sign Up
          Not sure about your diagnosis?
          Check Your Symptoms
          1 clinical trial found

            Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

            Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

            Enrollment Status: Recruiting
            Publish Date: August 06, 2025
            Intervention Type: Biological
            Study Phase: Phase 1/Phase 2

            Summary: The study objective is to see if IV IgG treatment in Recessive Dystrophic Epidermolysis Bullosa (RDEB) skin in conjunction with VYJUVEK treatment improves wound healing and affects the levels of C7 and HSV-1 antibody levels in serum. Fewer wounds, more rapidly healing wounds, and decreased C7 and HSV-1 antibodies could improve quality of life.

            Showing 1-1 of 1

            Last Updated: 10/31/2025